What is Monopar Therapeutics's investments?

Monopar Therapeutics (MNPR) reported investments of $84.95M in Q1 2026.

How has Monopar Therapeutics's investments changed year-over-year?

Monopar Therapeutics's investments increased by 472.4% year-over-year, from $14.84M to $84.95M.

Monopar Therapeutics MNPR Investments

Investments at other companies

Principal Financial GroupPFG

$110.86B+5.3%

CVS HealthCVS

$32.41B+12.1%

CignaCI

$18.9B+23.1%

Monster BeverageMNST

$770.4M—

EVERTECEVTC

$6.1M+16.2%

Dominion EnergyD

$9.47B+13.1%

Other financials

Income statement

See full

Revenue-—

Operating income-$5.2M-62.2%

Net income-$3.9M-48.3%

EPS (diluted)-$0.19—

Balance sheet

See full

Cash & equivalents$52.5M+32.3%

Total debt$230.4K+2,692%

Total equity$135.4M+153%

Total assets$138.0M+150%

Cash flow

See full

Operating cash flow-$3.5M+38.7%

Valuation

See full

Market cap$587.04M+192%

Enterprise value$534.72M+232%

Returns & leverage

See full

Return on equity-15.9%-6.6pp

Debt / equity0×0.0×

Current ratio56×—

Where this comes from

Reported directly by Monopar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Investments.

The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monopar Therapeutics's investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Monopar Therapeutics's investments?: Monopar Therapeutics (MNPR) reported investments of $84.95M in Q1 2026.
How has Monopar Therapeutics's investments changed year-over-year?: Monopar Therapeutics's investments increased by 472.4% year-over-year, from $14.84M to $84.95M.